Search Follow us

HBM Healthcare Investments (HBMN)

Business description

HBM Healthcare Investments (previously HBM BioVentures, renamed in 2012) aims to generate long-term gains through investment in private and public companies in the human medicine, biotech, medtech and diagnostics sectors, and related areas. It invests worldwide, predominantly in private companies, either directly or through funds, and many of its publicly listed holdings began as private equity investments.

Stock data

Market cap.€1091.3m
Last close€156.80
High / Low (52 weeks)€184.0 / €128.7
Stock market listingSW
Forecast net debt (m)N/A
Forecast gearing ratio (%)N/A
TeamInvestment Companies
SectorInvestment Companies

Other companies in sector Show

Aberdeen Asian Income Fund Aberdeen New Dawn Investment Trust
Aberdeen New Thai Investment Trust Aberdeen Private Equity Fund
Aberdeen Standard Equity Income Trust Aberdeen UK Tracker Trust
AcenciA Debt Strategies Acorn Income Fund
Adamas Finance Asia Alliance Trust
Altamir SCA Amphion Innovations
Atlantis Japan Growth Fund Aurelius
Bailador Tech Investments Baker Steel Resources Trust
Bankers Investment Trust (The) BB Biotech
BioPharma Credit BlackRock Emerging Europe
BlackRock Greater Europe Investment Trust BlackRock Hedge Selector
BlackRock Latin American Inv. Trust BMO Managed Portfolio Trust Growth Portfolio
BMO Managed Portfolio Trust Income Portfolio British Portfolio Trust
Brunner Investment Trust (The) Canadian General Investments
Carador Income Fund CFP Sanford DeLand Free Spirit Fund.
Charles Stanley City Natural Resources
Conversus Capital CQS Rig Finance Fund
CVC Credit Partners European Opps Detour Gold
Deutsche Beteiligungs Dexion Commodities
Diverse Income Trust (The) DouglasBay Capital
Dunedin Enterprise Investment Trust DW Catalyst Fund
Edinburgh Worldwide Investment Trust (The) EJF Investments
European Assets Trust European Investment Trust (The)
F&C Investment Trust F&C US Smaller Companies
Fidelity Asian Values Fidelity China Special Situations
Fidelity European Values Fidelity Japan Trust
Fidelity Special Values Finsbury Growth & Income Trust
Gartmore Growth Opportunities Gartmore Irish Growth Fund
Geiger Counter Limited Genesis Emerging Markets Fund
GLI Alternative Finance Global Resources Investment Trust
Golden Prospect Precious Metals Gulf Investment Fund
Hansa Trust (HAN) HarbourVest Global Private Equity
HarbourVest Senior Loans Europe Heliad Equity Partners
Henderson Alternative Strategies Trust Henderson Far East Income
Henderson Global Trust Henderson Global Trust
Henderson International Income Trust Heptagon
HSBC Infrastructure Company Infrastructure India
International Biotechnology Trust Invesco Asia Trust
Invesco Income Growth Trust Is Private Equity
JP Morgan Private Equity Limited JPMorgan Brazil Investment Trust
JPMorgan European Smaller Companies Trust JPMorgan Global Convertibles Income Fund
JPMorgan Global Growth & Income JPMorgan Indian Investment Trust
Jupiter Green Investment Trust Jupiter UK Growth Investment Trust
Jupiter US Smaller Companies JZ Capital Partners Limited
Lazard World Trust Fund Leaf Clean Energy Company
LMS Capital Lowland Investment Company
LPeC Marble Point Loan Financing
Martin Currie Asia Unconstrained Trust Martin Currie Global Portfolio Trust
Middlefield Canadian Income Miton Global Opportunities
Miton Income Opportunities Trust Murray International Trust
New City Energy Ocean Wilsons Holdings
Odyssean Investment Trust Pacific Assets Trust
Phaunos Timber Fund Polar Capital Global Healthcare Trust
Princess Private Equity Holding PXP Vietnam Fund
Rathbone Brothers RENN Universal Growth Investment Trust
Schroder AsiaPacific Fund Schroder Global Real Estate Securities
ScotGems Scottish Oriental Smaller Companies
Securities Trust of Scotland Seneca Global Income & Growth Trust
Sigma Capital Group Standard Life Investments Property Income Trust
Standard Life Private Equity Trust Standard Life UK Smaller Companies
Strategic Equity Capital Taiwan Fund (The)
Templeton Emerging Markets Investment Trust Tetragon Financial Group
The Biotech Growth Trust The Global Sustainability Trust
The Law Debenture Corporation The Merchants Trust
The North American Income Trust The Scottish Investment Trust
Tiso Blackstar Group Toscafund Asset Management
TR European Growth Trust UK Commercial Property REIT
Utilico Emerging Markets Trust Vietnam Enterprise Investments
Vietnam Holding Asset Management Vietnam Infrastructure Fund
VinaCapital Vietnam Opportunity Fund VinaLand
Vision Opportunity China Fund Volta Finance
WAM Active WAM Capital
WAM Research Witan Investment Trust
Witan Pacific Investment Trust Worldwide Healthcare Trust
YFM Equity Partners

Company news

Investment summary

HBM Healthcare Investments (HBMN) has reported extremely strong results for the first half of FY19 (to 30 September), with net earnings of CHF177m. While market conditions have turned negative in October, HBMN’s portfolio of private investments (c 36% of the total) and a market hedge covering c 20% of the listed portfolio should help to limit NAV volatility if the sell-off is prolonged. Results have been buoyed by good clinical data and a number of successful IPOs from the private portfolio, and HBMN’s managers are focused on finding new private opportunities to replace those now in the public portfolio. Ten new investments in H119 were diversified by clinical focus and geography (US, Europe and Asia). HBMN’s shares have re-rated substantially over the past year, arguably as a result of the ongoing evidence of successful execution of its strategy, as well as the high distribution policy (c 5% of NAV paid out each year).

Last updated on 29/10/2018

Key management

Andreas Wicki, CEO
Erwin Troxler, CFO

Company address

Bundesplatz 1
P.O. Box 1145
Zug
CH-6301
Switzerland
View website